MEDICAID COST AND UTILIZATION OUTCOMES IN OPIOID DEPENDENCE TREATMENT
Author(s)
Leslie DL1, Milchak W1, Gastfriend DR2, Herschman PL3, Bixler EO1, Meyer RE1
1Penn State University, Hershey, PA, USA, 2Treatment Research Institute, Newton, MA, USA, 3CRC Health Group, Inc, Cuppertino, CA, USA
OBJECTIVES: Little is known about the real-world utilization and cost outcomes associated with different treatment modalities for opioid dependence. This study sought to analyze pre- and post-treatment cost and service utilization data from a multi-site, retrospective, naturalistic study of opioid dependent adults in three Pennsylvania residential rehabilitation programs. METHODS: De-identified retrospective electronic data on 7,687 patients treated in one of three residential treatment centers in Pennsylvania were linked with Medicaid administrative data. Duration of Medicaid supported treatment and relative Medicaid costs and treatment patterns were compared across 4 different treatment modalities: 1) extended-release naltrexone (XR-NTX),
Conference/Value in Health Info
2014-05, ISPOR 2014, Palais des Congres de Montreal
Value in Health, Vol. 17, No. 3 (May 2014)
Code
PMH75
Topic
Economic Evaluation, Health Policy & Regulatory, Health Service Delivery & Process of Care
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies, Reimbursement & Access Policy, Treatment Patterns and Guidelines
Disease
Mental Health